JPRN-UMIN000007587已完成2 期
A Phase II Clinical Trial of Nedaplatin and Amurubicin Therapy for Advanced and Recurrent Squamous Cell Lung Cancer. - A Phase II Clinical Trial of Nedaplatin and Amurubicin Therapy for Advanced and Recurrent Squamous Cell Lung Cancer.
agasaki Thoracic Oncology Group0 个研究点目标入组 21 人开始时间: 2012年3月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
Partial response was observed in seven of 21 cases (ORR, 33.3%; 95% confidence interval [CI], 14.5-52.2). Disease control rate, which includes stable disease, was 71.4%. Median OS and PFS was 14.6 and 4.1 months, respectively.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Symptomatic or apparent interstitial pneumonia/lung fibrosis on X-ray image findings. 2)Patients wth uncontrollable fever. 3)Severe complications, such as cardiac. failure, uncontrollable diabetic or hypertension. 4)uncontrollable pleural effusion, pericardial effusionor ascites. 5)Active concomitant malignancy. 6)Severe drug allergies or history of drug hypersensitivity. 7)With active infection. 8)mental disorder. 9)Pregnant, lactating or women of child-bearing potential. 10)The case that is judged to be inadequacy for this study.
研究者
相似试验
已完成
1 期
Phase I/II trial of Nedaplatin and Docetaxel for advanced Squamous cell carcinoma of the lungchamotherapy-naive advanced squamous cell carcinoma of the lungJPRN-UMIN000001227ational Cancer Center Hospital East Thoracic Oncology Division24
已完成
1 期
Two institutional trial to evaluate the feasibility and efficacy of combined adjuvant therapy with gemcitabine and cisplatin for biliary tract cancerBiriary tract cancerJPRN-UMIN000001294Chiba Cancer Center30
已完成
2 期
Phase II study of neoadjuvant Letrozole combined with low dose metronomic Cyclophosphamide for postmenopausal women with Endocrine-responsive Breast Cancer (JBCRG-07)Postmenopausal, hormone-receptor positive and primary breast cancerJPRN-UMIN000001331Japan Breast Cancer Research Group (JBCRG)41
已完成
2 期
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinomathymic carcinomaJPRN-UMIN000010736Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital26
已完成
2 期
Phase II trial of docetaxel and carboplatin in patients with stage IVb or recurrent nonsquamous cell carcinoma of uterine cervixnonsquamous cell carcinoma of uterine cervixJPRN-UMIN000000564Sankai Gynecology Study Group50